|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/22 | (2006.01) |
| C07K 16/46 | (2006.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61P 27/06 | (2006.01) |
| (11) | Number of the document | 3495387 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18184973.8 |
| Date of filing the European patent application | 2013-07-11 | |
| (97) | Date of publication of the European application | 2019-06-12 |
| (45) | Date of publication and mention of the grant of the patent | 2021-09-01 |
| (46) | Date of publication of the claims translation | 2021-11-25 |
| (30) | Number | Date | Country code |
| 12176299 | 2012-07-13 | EP |
| (72) |
DUERR, Harald , DE
HERTING, Frank , DE
KLEIN, Christian , CH
REGULA, Joerg Thomas , DE
RUETH, Matthias , DE
STUBENRAUCH, Kay-Gunnar , DE
|
| (73) |
F. Hoffmann-La Roche AG ,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Bispecifiniai anti-VEGF / anti-ANG-2 antikūnai ir jų panaudojimas akių kraujagyslių ligoms gydyti |
| BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES AND THEIR USE IN THE TREATMENT OF OCULAR VASCULAR DISEASES |
| Payment date | Validity (years) | Amount | |
| 2025-06-19 | 13 | 289.00 EUR |
| 2026-07-11 |